featured
Efficacy of Downtitration or Treatment Withdrawal vs Continuous Dosing After Successful Treatment With Baricitinib in Patients With Atopic Dermatitis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The British Journal of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy of downtitration or treatment withdrawal compared with continuous dosing after successful treatment with baricitinib in patients with moderate-to-severe atopic dermatitis in a randomized substudy from the long-term extension study BREEZE-AD3
Br J Dermatol 2023 Feb 10;188(2)208-217, K Reich, E Simpson, A Wollenberg, R Bissonnette, M Abe, T Cardillo, J Janes, L Sun, S Chen, JI SilverbergFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.